<DOC>
	<DOC>NCT00901979</DOC>
	<brief_summary>This study will assess the effect of LCQ when added to metformin.</brief_summary>
	<brief_title>A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM)</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Sitagliptin Phosphate</mesh_term>
	<criteria>HbA1c from 7.010.0%, Stable Metformin dose CHF Class IIIIV, Liver disease Other protocoldefined inclusion/exclusion criteria may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Type 2 Diabetes</keyword>
</DOC>